Spero Therapeutics (SPRO) Insider Trading & Ownership $1.33 -0.02 (-1.48%) (As of 09/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Spero Therapeutics (NASDAQ:SPRO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.52%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$57,336.41 Get SPRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Spero Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SPRO Insider Buying and Selling by Quarter Ad Behind the MarketsOur #1 Ticker for the Rare "Retirement Window"We've only seen this happen three times in the past 20 years... And every time - like clockwork - it's minted an entire new class of millionaires.Click here for our #1 "Retirement Window" Stock >>> Spero Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/27/2024Ankit MahadeviaDirectorSell5,912$1.35$7,981.20 8/27/2024Sath ShuklaCEOSell2,757$1.35$3,721.95 8/27/2024Timothy KeutzerCOOSell2,213$1.35$2,987.55 8/5/2024Sath ShuklaCEOSell17,641$1.31$23,109.71 8/2/2024Sath ShuklaCEOSell14,800$1.32$19,536.00 (Data available from 1/1/2013 forward) SPRO Insider Trading Activity - Frequently Asked Questions Who is on Spero Therapeutics's Insider Roster? The list of insiders at Spero Therapeutics includes Ankit Mahadevia, Aquilo Capital Management, Llc, Kamal Hamed, Sath Shukla, and Timothy Keutzer. Learn more on insiders at SPRO. What percentage of Spero Therapeutics stock is owned by insiders? 4.52% of Spero Therapeutics stock is owned by insiders. Learn more on SPRO's insider holdings. Which Spero Therapeutics insiders have been selling company stock? The following insiders have sold SPRO shares in the last 24 months: Ankit Mahadevia ($41,609.26), Aquilo Capital Management, Llc ($4,279,041.00), Kamal Hamed ($50,159.92), Sath Shukla ($69,171.88), and Timothy Keutzer ($11,636.43). How much insider selling is happening at Spero Therapeutics? Insiders have sold a total of 2,024,856 Spero Therapeutics shares in the last 24 months for a total of $4,451,618.49 sold. More Insider Trading Tools from MarketBeat Related Companies: Corvus Pharmaceuticals Insider Trades Rezolute Insider Trades ESSA Pharma Insider Trades Poseida Therapeutics Insider Trades Adaptimmune Therapeutics Insider Trades Heron Therapeutics Insider Trades Biomea Fusion Insider Trades Alimera Sciences Insider Trades Acrivon Therapeutics Insider Trades MeiraGTx Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:SPRO) was last updated on 9/22/2024 by MarketBeat.com Staff From Our PartnersWall Street Insider Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored[SHOCKING] Crypto Document Leak…A shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spero Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SPRO Stock Alerts